Willemsen M H, Vulto-van Silfhout A T, Nillesen W M, Wissink-Lindhout W M, van Bokhoven H, Philip N, Berry-Kravis E M, Kini U, van Ravenswaaij-Arts C M A, Delle Chiaie B, Innes A M M, Houge G, Kosonen T, Cremer K, Fannemel M, Stray-Pedersen A, Reardon W, Ignatius J, Lachlan K, Mircher C, Helderman van den Enden P T J M, Mastebroek M, Cohn-Hokke P E, Yntema H G, Drunat S, Kleefstra T
Department of Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
Mol Syndromol. 2012 Apr;2(3-5):202-212. doi: 10.1159/000335648. Epub 2012 Jan 24.
Kleefstra syndrome is characterized by the core phenotype of developmental delay/intellectual disability, (childhood) hypotonia and distinct facial features. The syndrome can be either caused by a microdeletion in chromosomal region 9q34.3 or by a mutation in the euchromatin histone methyltransferase 1 (EHMT1) gene. Since the early 1990s, 85 patients have been described, of which the majority had a 9q34.3 microdeletion (>85%). So far, no clear genotype-phenotype correlation could be observed by studying the clinical and molecular features of both 9q34.3 microdeletion patients and patients with an intragenic EHMT1 mutation. Thus, to further expand the genotypic and phenotypic knowledge about the syndrome, we here report 29 newly diagnosed patients, including 16 patients with a 9q34.3 microdeletion and 13 patients with an EHMT1 mutation, and review previous literature. The present findings are comparable to previous reports. In addition to our former findings and recommendations, we suggest cardiac screening during follow-up, because of the possible occurrence of cardiac arrhythmias. In addition, clinicians and caretakers should be aware of the regressive behavioral phenotype that might develop at adolescent/adult age and seems to have no clear neurological substrate, but is rather a so far unexplained neuropsychiatric feature.
克莱夫斯特拉综合征的核心表型为发育迟缓/智力残疾、(儿童期)肌张力减退和独特的面部特征。该综合征可由染色体区域9q34.3的微缺失或常染色质组蛋白甲基转移酶1(EHMT1)基因的突变引起。自20世纪90年代初以来,已报道了85例患者,其中大多数存在9q34.3微缺失(>85%)。迄今为止,通过研究9q34.3微缺失患者和EHMT1基因内突变患者的临床和分子特征,未观察到明确的基因型-表型相关性。因此,为了进一步扩展关于该综合征的基因型和表型知识,我们在此报告29例新诊断的患者,包括16例9q34.3微缺失患者和13例EHMT1突变患者,并回顾以前的文献。目前的发现与以前的报告相似。除了我们以前的发现和建议外,由于可能发生心律失常,我们建议在随访期间进行心脏筛查。此外,临床医生和护理人员应意识到青少年/成年期可能出现的退行性行为表型,这种表型似乎没有明确的神经学基础,而是一种迄今为止无法解释的神经精神特征。